NKT Cells Provide Help for Dendritic Cell-Dependent Priming of MHC Class I-Restricted CD8+ T Cells In Vivo 1

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of Immunology

• Publication date

  2003-03-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.4049/jimmunol.170.5.2540PMID 12594280
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prolonged IFN-γ–producing NKT response induced with α-galactosylceramide–loaded DCs

  2002cited by this paper
• Visualizing priming of virus-specific CD8+ T cells by infected dendritic cells in vivo

  2002cited by this paper
• NK T Cells Contribute to Expansion of CD8+ T Cells and Amplification of Antiviral Immune Responses to Respiratory Syncytial Virus

  2002cited by this paper
• Activating Immunity in the Liver. II. IFN-β Attenuates NK Cell-Dependent Liver Injury Triggered by Liver NKT Cell Activation1

  2002cited by this paper
• Dendritic cells pulsed with exogenous hepatitis B surface antigen particles efficiently present epitopes to MHC class I‐restricted cytotoxic T cells

  2002cited by this paper
• Natural Killer T Cell Ligand α-Galactosylceramide Enhances Protective Immunity Induced by Malaria Vaccines

  2002cited by this paper
• Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs.

  2002cited by this paper
• Adjuvants of Immunity

  2002cited by this paper
• Complementary Dendritic Cell–activating Function of CD8+ and CD4+ T Cells

  2002cited by this paper
• Critical contribution of IFN-gamma and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of alpha-galactosylceramide.

  2001cited by this paper
• Critical contribution of IFN‐γ and NK cells, but not perforin‐mediated cytotoxicity, to anti‐metastatic effect of α‐galactosylceramide

  2001cited by this paper
• CD1-specific T cells in microbial immunity.

  2001cited by this paper
• Th1 Cytokine-Conditioned Bone Marrow-Derived Dendritic Cells Can Bypass the Requirement for Th Functions During the Generation of CD8+ CTL1

  2001cited by this paper
• IL-12/IL-18-Dependent IFN-γ Release by Murine Dendritic Cells1

  2001cited by this paper
• IL-12/IL-18-dependent IFN-gamma release by murine dendritic cells.

  2001cited by this paper
• Longevity of Antigen Presentation and Activation Status of APC Are Decisive Factors in the Balance Between CTL Immunity Versus Tolerance1

  2001cited by this paper
• Induction of CTL and Nonpolarized Th Cell Responses by CD8α+ and CD8α− Dendritic Cells1

  2001cited by this paper
• Potent expansion of human natural killer T cells using alpha-galactosylceramide (KRN7000)-loaded monocyte-derived dendritic cells, cultured in the presence of IL-7 and IL-15.

  2001cited by this paper
• Activating Immunity in the Liver. I. Liver Dendritic Cells (but Not Hepatocytes) Are Potent Activators of IFN-γ Release by Liver NKT Cells1

  2001cited by this paper
• Tumor-Specific CD4+ T Cells Have a Major “Post-Licensing” Role in CTL Mediated Anti-Tumor Immunity1

  2000cited by this paper
• Selective Bystander Proliferation of Memory CD4+ and CD8+ T Cells Upon NK T or T Cell Activation

  2000cited by this paper
• CpG-DNA Activates In Vivo T Cell Epitope Presenting Dendritic Cells to Trigger Protective Antiviral Cytotoxic T Cell Responses1

  2000cited by this paper
• Cd40-Independent Pathways of T Cell Help for Priming of Cd8+ Cytotoxic T Lymphocytes

  2000cited by this paper
• Ongoing Murine T1 or T2 Immune Responses to the Hepatitis B Surface Antigen Are Excluded from the Liver that Expresses Transgene-Encoded Hepatitis B Surface Antigen1

  2000cited by this paper
• Analysis of Human Va24 CD4 NKT Cells Activated by a-Glycosylceramide-Pulsed Monocyte-Derived Dendritic Cells

  2000cited by this paper
• Immunostimulatory DNA-based vaccines induce cytotoxic lymphocyte activity by a T-helper cell-independent mechanism

  2000cited by this paper
• α-Galactosylceramide-activated Vα14 natural killer T cells mediate protection against murine malaria.

  2000cited by this paper
• Analysis of human V alpha 24+ CD4+ NKT cells activated by alpha-glycosylceramide-pulsed monocyte-derived dendritic cells.

  2000cited by this paper
• Immature Dendritic Cells Acquire Cd8+Cytotoxic T Lymphocyte Priming Capacity upon Activation by T Helper Cell–Independent or–Dependent Stimuli

  2000cited by this paper
• Analysis of Human Vα24+ CD4+ NKT Cells Activated by α-Glycosylceramide-Pulsed Monocyte-Derived Dendritic Cells

  2000cited by this paper
• The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes.

  2000cited by this paper
• The Anti-Tumor Activity of IL-12: Mechanisms of Innate Immunity That Are Model and Dose Dependent1

  2000cited by this paper
• Mature dendritic cells boost functionally superior CD8(+) T-cell in humans without foreign helper epitopes.

  2000cited by this paper
• alpha -galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malaria.

  2000cited by this paper
• CD4+ T Cell Priming Accelerates the Clearance of Sendai Virus in Mice, but Has a Negative Effect on CD8+ T Cell Memory1

  2000cited by this paper
• Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells

  2000cited by this paper
• CpG DNA Induces Maturation of Dendritic Cells with Distinct Effects on Nascent and Recycling MHC-II Antigen-Processing Mechanisms

  2000cited by this paper
• Natural T cells: cranking up the immune system by prompt cytokine secretion.

  2000cited by this paper
• DO11.10 and OT-II T Cells Recognize a C-Terminal Ovalbumin 323–339 Epitope1

  2000cited by this paper
• The Natural Killer T (NKT) Cell Ligand α-Galactosylceramide Demonstrates Its Immunopotentiating Effect by Inducing Interleukin (IL)-12 Production by Dendritic Cells and IL-12 Receptor Expression on NKT Cells

  1999cited by this paper
• Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells.

  1999cited by this paper
• Impaired ability of MHC class II-/- dendritic cells to provide tumor protection is rescued by CD40 ligation.

  1999cited by this paper
• Polyriboinosinic polyribocytidylic acid (poly(I:C)) induces stable maturation of functionally active human dendritic cells.

  1999cited by this paper
• CpG-Containing Oligonucleotides Are Efficient Adjuvants for Induction of Protective Antiviral Immune Responses with T-Cell Peptide Vaccines

  1999cited by this paper
• CTL priming by CD8+ and CD8– dendritic cells in vivo

  1999cited by this paper
• Cutting edge: inhibition of experimental tumor metastasis by dendritic cells pulsed with alpha-galactosylceramide.

  1999cited by this paper
• Immunization with α‐galactosylceramide polarizes CD1‐reactive NK T cells towards Th2 cytokine synthesis

  1999cited by this paper
• Dendritic cells need T cell help to prime cytotoxic T cell responses to strong antigens

  1999cited by this paper
• Adjuvants that enhance priming of cytotoxic T cells to a Kb-restricted epitope processed from exogenous but not endogenous hepatitis B surface antigen.

  1999cited by this paper
• Vaccination with Mage-3a1 Peptide–Pulsed Mature, Monocyte-Derived Dendritic Cells Expands Specific Cytotoxic T Cells and Induces Regression of Some Metastases in Advanced Stage IV Melanoma

  1999cited by this paper
• CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells.

  1999cited by this paper
• Maturation, Activation, and Protection of Dendritic Cells Induced by Double-stranded RNA

  1999cited by this paper
• Cutting edge: activation of NK T cells by CD1d and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype.

  1999cited by this paper
• Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity.

  1999cited by this paper
• Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells.

  1999cited by this paper
• Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent.

  1999cited by this paper
• Superdominance among immunodominant H-2Kb-restricted epitopes and reversal by dendritic cell-mediated antigen delivery.

  1998cited by this paper
• Specific T Helper Cell Requirement for Optimal Induction of Cytotoxic T Lymphocytes against Major Histocompatibility Complex Class II Negative Tumors

  1998cited by this paper
• Help for cytotoxic-T-cell responses is mediated by CD40 signalling

  1998cited by this paper
• T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions

  1998cited by this paper
• A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell

  1998cited by this paper
• CD1d-mediated Recognition of an α-Galactosylceramide by Natural Killer T Cells Is Highly Conserved through Mammalian Evolution

  1998cited by this paper
• Virus-specific CD8(+) T cell numbers are maintained during gamma-herpesvirus reactivation in CD4-deficient mice.

  1998cited by this paper
• Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells

  1998cited by this paper
• CTL effector function within the central nervous system requires CD4+ T cells.

  1998cited by this paper
• Similar as well as distinct MHC class I‐binding peptides are generated by exogenous and endogenous processing of hepatitis B virus surface antigen

  1998cited by this paper
• Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA.

  1998cited by this paper
• Dendritic Cells Efficiently Induce Protective Antiviral Immunity

  1998cited by this paper
• Critical role of NK1+ T cells in IL-12-induced immune responses in vivo.

  1998cited by this paper
• Cutting Edge: Critical Role of NK1+ T Cells in IL-12-Induced Immune Responses In Vivo

  1998cited by this paper
• Immunoglobulin E Production in the Absence of Interleukin-4-Secreting CD1-Dependent Cells

  1997cited by this paper
• Induction of a CD8+ Cytotoxic T Lymphocyte Response by Cross-priming Requires Cognate CD4+ T Cell Help

  1997cited by this paper
• Long-lasting CD8 T cell memory in the absence of CD4 T cells or B cells

  1996cited by this paper
• A role for CD4+ NK1.1+ T lymphocytes as major histocompatibility complex class II independent helper cells in the generation of CD8+ effector function against intracellular infection

  1996cited by this paper
• CD1-restricted CD4+ T cells in major histocompatibility complex class II-deficient mice

  1995cited by this paper
• Inactivated influenza virus, when presented on dendritic cells, elicits human CD8+ cytolytic T cell responses

  1995cited by this paper
• Targeted disruption of the MHC class II Aa gene in C57BL/6 mice.

  1993cited by this paper
• Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor

  1992cited by this paper
• Mice lacking MHC class II molecules.

  1991cited by this paper
• In vivo induction of cytotoxic T cell response by a free synthetic peptide requires CD4+ T cell help.

  1991cited by this paper

• Recruiting Natural Killer T Cells to Improve Vaccination: Lessons from Preclinical and Clinical Studies.

  2024cites this paper
• A randomised controlled trial of long NY-ESO-1 peptide-pulsed autologous dendritic cells with or without alpha-galactosylceramide in high-risk melanoma

  2023cites this paper
• Glycolipid‐peptide conjugate vaccines elicit CD8 + T‐cell responses and prevent breast cancer metastasis

  2022cites this paper
• Immunomodulatory potential of in vivo natural killer T (NKT) activation by NKTT320 in Mauritian-origin cynomolgus macaques

  2022cites this paper
• Cross Talk Between Natural Killer T and Dendritic Cells and Its Impact on T Cell Responses in Infections

  2022cites this paper
• Invariant natural killer T cells balance B cell immunity

  2021cites this paper
• The role of NKT cells in gastrointestinal cancers

  2021cites this paper
• Harnessing NKT cells for vaccination

  2021cites this paper
• Adjuvant and immunomodulatory potential of Natural Killer T (NKT) activation by NKTT320

  2021cites this paper
• Killing efficiency affected by mutually modulated PD-1 and PD-L1 expression via NKT-hepatoma cell interactions.

  2020cites this paper
• Targeted Co-delivery of Tumor Antigen and α-Galactosylceramide to CD141+ Dendritic Cells Induces a Potent Tumor Antigen-Specific Human CD8+ T Cell Response in Human Immune System Mice

  2020cites this paper
• Using agonists for iNKT cells in cancer therapy.

  2020cites this paper
• Supramolecular organization of α-galactosylceramide in pure dispersions and in cationic DODAB bilayers.

  2020cites this paper
• NKT Cell–Driven Enhancement of Antitumor Immunity Induced by Clec9a-Targeted Tailorable Nanoemulsion

  2019cites this paper
• Enhancing T cell responses and tumour immunity by vaccination with peptides conjugated to a weak NKT cell agonist.

  2019cites this paper
• Natural Killer T Cells and Mucosal-Associated Invariant T Cells in Lung Infections

  2018cites this paper
• Therapeutic implications of NK cell regulation of allogeneic CD8 T cell-mediated immune responses stimulated through the direct pathway of antigen presentation in transplantation

  2018cites this paper
• Co-delivery of the NKT agonist α-galactosylceramide and tumor antigens to cross-priming dendritic cells breaks tolerance to self-antigens and promotes antitumor responses

  2017cites this paper
• Optimisation de l'activité immunostimulatrice des lymphocytes T Natural Killer invariants : conséquences sur l'immunité anti-tumorale

  2017cites this paper
• Synthetic glycolipid activators of natural killer T cells as immunotherapeutic agents

  2016cites this paper
• Co-operation of α-galactosylceramide-loaded tumour cells and TLR9 agonists induce potent anti-tumour responses in a murine colon cancer model.

  2016cites this paper
• Bio-conjugate Approaches for Improved Targeted Toll-like receptor based Immune Adjuvant Vaccines

  2016cites this paper
• Exosomes : immunomodulators in cancer and therapy

  2016cites this paper
• Antitumor Responses of Invariant Natural Killer T Cells

  2015cites this paper
• Immunotherapy of Cancer: Reprogramming Tumor/Immune Cellular Crosstalk to Improve Anti-Tumor Efficacy

  2015cites this paper
• Elevated expression of LAG-3, but not PD-1, is associated with impaired iNKT cytokine production during chronic HIV-1 infection and treatment

  2015cites this paper
• Mucopolysaccharide diseases: A complex interplay between neuroinflammation, microglial activation and adaptive immunity

  2014cites this paper
• Adoptive cellular therapy of cancer: exploring innate and adaptive cellular crosstalk to improve anti-tumor efficacy.

  2014cites this paper
• Optimizing NKT cell ligands as vaccine adjuvants.

  2014cites this paper
• Type I NKT‐cell‐mediated TNF‐α is a positive regulator of NLRP3 inflammasome priming

  2014cites this paper
• A self-adjuvanting vaccine induces cytotoxic T lymphocytes that suppress allergy.

  2014cites this paper
• Biology of CD1- and MR1-restricted T cells.

  2014cites this paper
• Enhancing T Cell Immune Responses by B Cell-based Therapeutic Vaccine Against Chronic Virus Infection

  2014cites this paper
• Peripheral blood mononuclear cells of patients with breast cancer can be reprogrammed to enhance anti-HER-2/neu reactivity and overcome myeloid-derived suppressor cells

  2013cites this paper
• Pathogen in Response to an Intracellular NK Cells Regulate CD8+ T Cell Effector

  2013cites this paper
• Antigen-Specific Cytotoxic T Cell Responses Cells Promote Tumor-Associated -Producing Human Invariant NKT γ IFN-

  2013cites this paper
• Role of Natural Killer T Cells In Immunogenic Chemotherapy for Breast Cancer

  2012cites this paper
• This information is current as Mediated Immunity −-Galactosylceramide α T Cells in δγ Role of

  2012cites this paper
• This information is current as Dendritic Cells by CD 1 d Overexpression Human Embryonic Stem Cell-Derived Enhancing Immunostimulatory Function

  2012cites this paper
• Award Number: W81XWH-11-1-0585 TITLE: ROLE OF NATURAL KILLER T CELLS IN IMMUNOGENIC CHEMOTHERAPY FOR BREAST CANCER

  2012cites this paper
• Role of gd T Cells in a-Galactosylceramide-Mediated Immunity

  2012cites this paper
• Role of γδ T Cells in α-Galactosylceramide–Mediated Immunity

  2012cites this paper
• Induced pluripotency as a potential path towards iNKT cell-mediated cancer immunotherapy

  2012cites this paper
• Innate Immune Response and Inflammation: Roles in Pathogenesis and Protection (Anaplasmataceae)

  2012cites this paper
• Invariant NKT Cell-Based Vaccine Strategies

  2012cites this paper
• Introduction: Mechanisms of NKT-Cell-Mediated Adjuvant Activity and Function of iPS-Derived NKT Cells

  2012cites this paper
• Enhancing Immunostimulatory Function of Human Embryonic Stem Cell-Derived Dendritic Cells by CD1d Overexpression

  2012cites this paper
• Chapter 5 CXCR 5 regulates Chlamydia tubal pathology in mice and humans

  2011cites this paper
• Comparison of Clinical and Immunological Effects of Intravenous and Intradermal Administration of α-GalactosylCeramide (KRN7000)-Pulsed Dendritic Cells

  2011cites this paper
• Exploiting the Role of Endogenous Lymphoid-Resident Dendritic Cells in the Priming of NKT Cells and CD8+ T Cells to Dendritic Cell-Based Vaccines

  2011cites this paper
• Molecular Pathogenesis of EBV Susceptibility in XLP as Revealed by Analysis of Female Carriers with Heterozygous Expression of SAP

  2011cites this paper
• Administration of α‐galactosylceramide impairs the survival of dendritic cell subpopulations in vivo

  2011cites this paper
• Dendritic cell internalization of α-galactosylceramide from CD8 T cells induces potent antitumor CD8 T-cell responses.

  2011cites this paper
• Engagement of glycosylphosphatidylinositol‐anchored proteins results in enhanced mouse and human invariant natural killer T cell responses

  2011cites this paper
• The specialized iNKT cell system recognizes glycolipid antigens and bridges the innate and acquired immune systems with potential applications for cancer therapy.

  2010cites this paper
• Attenuation of invariant natural killer T-cell anergy induction through intradermal delivery of alpha-galactosylceramide.

  2010cites this paper
• Invariant NKT Cells Are Required for Antitumor Responses Induced by Host-Versus-Graft Responses

  2010cites this paper
• Design of a potent CD1d-binding NKT cell ligand as a vaccine adjuvant

  2010cites this paper
• Alternative cross-priming through CCL17-CCR4-mediated attraction of CTLs toward NKT cell–licensed DCs

  2010cites this paper
• The invariant NKT cell subset in anti‐viral defenses: a dark horse in anti‐influenza immunity?

  2010cites this paper
• Contribution of guanine nucleotide binding protein beta polypeptide 3 (GNB3) and lymphocyte activation gene 3 (LAG-3) to HIV susceptibility and immune dysfunction

  2010cites this paper
• Adjuvant activity mediated by iNKT cells.

  2010cites this paper
• IFN-γ production downstream of NKT cell activation in mice infected with influenza virus enhances the cytolytic activities of both NK cells and viral antigen-specific CD8+ T cells.

  2010cites this paper
• This information is current as Host-Versus-Graft Responses Antitumor Responses Induced by Invariant NKT Cells Are Required for

  2010cites this paper
• Immune Responses in Perforin Deficient Mice

  2009cites this paper
• MHC class II‐dependent T–T interactions create a diverse, functional and immunoregulatory reaction circle

  2009cites this paper
• Harnessing human CD1d restricted T cells for tumor immunity: progress and challenges.

  2009cites this paper
• Harnessing invariant NKT cells in vaccination strategies

  2009cites this paper
• Skin Dendritic Cells Lymph Node Independently of Migratory Presented to NKT Cells in the Draining Glycolipids Injected into the Skin Are

  2009cites this paper
• Antigen Presentation by CD1 Lipids, T Cells, and NKT Cells in Microbial Immunity.

  2009cites this paper
• Endogenous IL-21 Restricts CD8+ T Cell Expansion and Is not Required for Tumor Immunity1

  2009cites this paper
• Glycolipids Injected into the Skin Are Presented to NKT Cells in the Draining Lymph Node Independently of Migratory Skin Dendritic Cells1

  2009cites this paper
• Immunity Expansion and Is not Required for Tumor T Cell + Endogenous IL-21 Restricts CD 8

  2009cites this paper
• Modulation of NKT cells and Th1/Th2 imbalance after α-GalCer treatment in progressive load-trained rats

  2009cites this paper
• Chapter 1 Antigen Presentation by CD1

  2009cites this paper
• IFN-γ-Producing Human Invariant NKT Cells Promote Tumor-Associated Antigen-Specific Cytotoxic T Cell Responses1

  2008cites this paper
• Exploiting dendritic cells and natural killer T cells in immunotherapy against malignancies.

  2008cites this paper
• Regulatory Roles of CD1d-Restricted NKT Cells in the Induction of Toxic Shock-Like Syndrome in an Animal Model of Fatal Ehrlichiosis

  2008cites this paper
• Atlas effectors of anti-tumor immunity

  2008influential citation
• Dendritic Cells Negative Control of CD8 T Cell Priming by Type I IFN-Induced, NKT Cell-Mediated

  2008cites this paper
• An adjuvant role of in situ dendritic cells (DCs) in linking innate and adaptive immunity.

  2008cites this paper
• Importance of NKT Cells in Resistance to Herpes Simplex Virus, Fate of Virus-Infected Neurons, and Level of Latency in Mice

  2008cites this paper
• Type I IFN-Induced, NKT Cell-Mediated Negative Control of CD8 T Cell Priming by Dendritic Cells1

  2008cites this paper
• Structural and functional aspects of lipid binding by CD1 molecules.

  2008cites this paper
• The role of NKT cells in tumor immunity.

  2008cites this paper
• Glycolipid ligands of invariant natural killer T cells as vaccine adjuvants

  2008cites this paper
• Natural killer T (NKT) cells: Immunophenotype, functional characteristics and significance in clinical practice

  2008cites this paper
• Chemotherapy-induced immunosuppression is restored by a fermented soybean extract: a proof of concept clinical trial

  2007cites this paper
• In vivo CTL Activity Induced by Prime-boost Vaccination using Recombinant Vaccinia Virus and DNA Vaccine Expressing Epitope Specific for CD8 T Cells

  2007cites this paper
• Harnessing NKT cells for therapeutic applications.

  2007cites this paper
• A single intranasal immunization with inactivated influenza virus and alpha-galactosylceramide induces long-term protective immunity without redirecting antigen to the central nervous system.

  2007cites this paper
• CD8⁺ T 세포 특이 Epitope 발현 Recombinant Vaccinia Virus와 DNA Vaccine을 이용한 Prime-boost 접종법에 의하여 유도되는 in vivo CTL Activity

  2007cites this paper
• Type I IFN-Producing CD4 Vα14i NKT Cells Facilitate Priming of IL-10-Producing CD8 T Cells by Hepatocytes1

  2007cites this paper
• Innate Vα14+ natural killer T cells mature dendritic cells, leading to strong adaptive immunity

  2007cites this paper
• Immuno-modulatory functions of CD1d-restricted natural killer T cells

  2006cites this paper
• Graft-versus-host disease in recipients of grafts from natural killer T cell-deficient (Jalpha281(-/-)) donors.

  2006cites this paper
• Comparative gene expression analysis of NKT cell subpopulations

  2006cites this paper
• Suppressor of cytokine signaling 1 inhibition strategy to enhance anti-HIV vaccination

  2006cites this paper
• Improving Antitumor Immune Responses by Circumventing Immunoregulatory Cells and Mechanisms

  2006cites this paper
• Graft‐versus‐host disease in recipients of grafts from natural killer T cell‐deficient (Jα281–/–) donors

  2006cites this paper